Acceleron Pharma
XLRN
#1821
Rank
S$14.10 B
Marketcap
S$230.59
Share price
0.00%
Change (1 day)
14,847.38%
Change (1 year)

Earnings for Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -S$0.35 Billion

According to Acceleron Pharma's latest financial reports the company's current earnings are S$0.11 Billion. In 2020 the company made an earning of -S$0.22 Billion a decrease over its 2019 earnings that were of -S$0.18 Billion.

Earnings history for Acceleron Pharma from 2012 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$0.35 Billion59.05%
2020-S$0.22 Billion22.62%
2019-S$0.18 Billion9.67%
2018-S$0.17 Billion13.12%
2017-S$0.15 Billion92.99%
2016-S$73.52 Million-6.39%
2015-S$78.54 Million20.95%
2014-S$64.94 Million154.15%
2013-S$25.55 Million-36.22%
2012-S$40.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B-7,427.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.98 B-2,827.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.25 B-4,425.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$7.33 B-2,325.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.43 Million-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-S$0.26 Billion-21.79%๐Ÿ‡บ๐Ÿ‡ธ USA